Evaluation and management of premenstrual syndrome in clinical psychiatric practice.
Premenstrual syndrome, a long-recognized entity, has been the subject of increased interest in recent years. Many women, perhaps a majority, experience some premenstrual symptoms; a minority have severe symptoms. The authors explore possible links to psychiatric disorders, outline general evaluation and management approaches, and discuss specific implications for the treatment of psychiatric patients who have a menstrually related component to their symptoms. It is hoped that a continuing understanding of this complex area may further our conceptualization and treatment of both premenstrual symptoms and psychiatric disorders.
D001971:Bromocriptine / Q000627:therapeutic use; D003276:Contraceptives, Oral / Q000627:therapeutic use; D015444:Exercise; D005260:Female; D005526:Food, Formulated; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D001523:Mental Disorders / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D011293:Premenstrual Syndrome / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy; D011374:Progesterone / Q000627:therapeutic use; D011570:Psychiatry; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D003276:Contraceptives, Oral; D011619:Psychotropic Drugs; D014815:Vitamins; D016651:Lithium Carbonate; D001971:Bromocriptine; D011374:Progesterone; D008094:Lithium